Incyclix Bio
Drug Discovery
Incyclix Bio valuation and funding history | Last updated: March 31, 2022 | 1 funding rounds
Current Valuation
N/A
As of March 31, 2022
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series B)
$41.3M
Last Funding
Mar 2022
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| March 31, 2022 | Early Stage VC (Series B) | $41.3M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Incyclix Bio is currently valued at N/A as of March 31, 2022.
What is Incyclix Bio Worth in 2026?
Incyclix Bio is a leading private company in the Drug Discovery sector. Track Incyclix Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Incyclix Bio Valuation is Determined
Private company valuations like Incyclix Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.